Top of page
Lawyers

Richard D. Truesdell, Jr.

Lawyers

Filters

Valero Energy $1.5 billion senior notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Valero Energy Corporation of $1.5 billion aggregate principal amount of its 2.700% senior notes due…
Home Depot $5 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $750 million aggregate principal amount of 2.500% notes due 2027, $1…
Cigna $3.5 billion senior notes offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of $1.5 billion aggregate principal amount of 2.400% senior notes due…
Freeport-McMoRan $1.3 billion notes offering
Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.3 billion of senior notes. The offering consisted of two tranches of senior notes,…
MSCI $400 million notes offering
Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…
W.W. Grainger $500 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by W.W. Grainger of $500 million aggregate principal amount of 1.85% senior notes due 2025. Headquartered in Lake Forest,…
Black Diamond Therapeutics $231.3 million IPO
Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…
Zai Lab $300 million follow-on offering of ADSs
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Applied Therapeutics $143.4 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…
Back to top